ESports

• Notice of the Annual General Meeting of shareholders 2025 of Telefonaktiebolaget LM Ericsson

  

  STOCKHOLM,Feb. 20,2025-- The shareholders ofTelefonaktiebolaget LM Ericsson (reg. no 556016-0680) (the "Company" or "Ericsson") are invited to participate in the Annual General Mee

  02-21

  Details

• Starburst Closes Record FY25, Fueled by Rising AI Demand and Growing Enterprise Momentum

  

  BOSTON,Feb. 20,2025--Starburst,the data platform for apps and AI,announced a record FY25 close,driven by strong demand from enterprise customers:

  02-21

  Details

• FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA

  

  YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1

  02-21

  Details

• Milken Institute to Present the Second Global Investors' Symposium in Hong Kong, Charting a Path for Connecting Global Markets

  

  The flagship investment-focused Symposium builds on the success of the inaugural event and will prioritize connecting global investors,chief executives,business leaders,and policymakers around the wo

  02-21

  Details

• Youdao Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

  

  HANGZHOU,China,Feb. 20,2025-- Youdao,Inc. ("Youdao" or the "Company") (NYSE: DAO),an intelligent learning company with industry-leading technology in China,today announced its unau

  02-21

  Details

• Ampace Obtains Amazon Climate Pledge Friendly Certification

  

  Ampace Obtains Amazon Climate Pledge Friendly Certification,Pioneering Zero-Carbon Energy Solutions with Green Tech

  02-21

  Details

• Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer

  

  HONG KONG,Feb. 21,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in itsmulticenter,randomized,double

  02-21

  Details

• Bestqool Unveils Four-Wavelength Pro Series and Second-Gen Mobile Stand at Original Price

  

  NEW YORK,Feb. 21,2025-- In a recent announcement,Bestqool is upgrading both the Pro100 and Pro200 to the four-wavelength configuration (630 nm,660 nm,850 nm,940 nm) as the Pro 300,without increasing

  02-21

  Details

• 100MW/331MWh Bramley Energy Storage Project in the UK Now Operational, Thanks to BW ESS and Sungrow

  

  BW ESS and Sungrow celebrate the successful commercial operation of the 100MW/331MWh Bramley battery energy storage system (BESS),a milestone in strengthening UK energy security.

  02-20

  Details

• Ascletis Announces Positive Interim Results from First Two Cohorts of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30

  

  - ASC30 oral once-daily tablet demonstrated a 6.3% meanbody weight reduction from baseline after 28-day treatment in multiple ascending dose (MAD) cohort 2 (weekly titrations of 2 mg,10 mg,20 mg,and 4

  02-20

  Details